- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Del buys Villa Sistemi Medicali
X-ray manufacturer Del Global Technologies has purchased a 19% stake in Milan-based Villa Sistemi Medicali, and has obtained an exclusive option to increase its ownership interest to 80% of the company’s capital stock. Villa Sistemi produces
X-ray manufacturer Del Global Technologies has purchased a 19% stake in Milan-based Villa Sistemi Medicali, and has obtained an exclusive option to increase its ownership interest to 80% of the companys capital stock. Villa Sistemi produces radiographic/fluoroscopic technology, including portable and dental imaging systems. It has annual sales of approximately $20 million.
The move is part of Valhalla, NY-based Dels efforts to extend its reach as a supplier of medical imaging equipment worldwide. Del has been pursuing potential acquisitions, both in the U.S. and internationally, as the company seeks to expand (SCAN 2/17/99). The firms last purchase was in 1998, when it bought the x-ray assets of Acoma Medical Imaging of Wheeling, IL, for $1.4 million over three years (SCAN 12/16/98). That deal brought Del into the R/F market for the first time by giving it access to a cost-effective system manufactured by Acoma.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
